[Evaluation of the efficacy of aflibercept's in the treatment of neovascular age-related macular degeneration in treatment-naive and switched patients. Report of 86 cases]. (Record no. 25844957)

MARC details
000 -LEADER
fixed length control field 01545 a2200397 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250517084943.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201701s 0 0 fre d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1773-0597
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1016/j.jfo.2015.10.009
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Maringe, E
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20170130
245 00 - TITLE STATEMENT
Title [Evaluation of the efficacy of aflibercept's in the treatment of neovascular age-related macular degeneration in treatment-naive and switched patients. Report of 86 cases].
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Journal francais d'ophtalmologie
Date of publication, distribution, etc. Mar 2016
300 ## - PHYSICAL DESCRIPTION
Extent 255-60 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Observational Study
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Substitution
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Follow-Up Studies
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element France
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Intravitreal Injections
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Macular Degeneration
General subdivision complications
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Ranibizumab
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Receptors, Vascular Endothelial Growth Factor
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Recombinant Fusion Proteins
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Retinal Neovascularization
General subdivision complications
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Retrospective Studies
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Treatment Outcome
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Visual Acuity
General subdivision drug effects
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Letesson, E
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Duncombe, A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Muraine, M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Genevois, O
773 0# - HOST ITEM ENTRY
Title Journal francais d'ophtalmologie
Related parts vol. 39
-- no. 3
-- p. 255-60
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1016/j.jfo.2015.10.009">https://doi.org/10.1016/j.jfo.2015.10.009</a>
Public note Available from publisher's website

No items available.